$ARAY News

Accuray Incorporated 2026 Q4 - Results - Earnings Call Presentation

Accuray Incorporated (ARAY) Q4 2026 Earnings Call Transcript

Accuray Q4 2026 Earnings Call: Complete Transcript

Accuray Says Not Providing Formal Revenue Or Adjusted EBITDA Guidance For Fiscal 2027 At This Time

Accuray Q4 EPS $(0.02) Beats $(0.10) Estimate, Sales $100.919M Miss $105.300M Estimate

Accuray to Report Fourth Quarter Fiscal 2026 Financial Results on August 19, 2026

Accuray Enters Agreements With TCW Asset Management to Boost Financial Position, Liquidity

Accuray Announces Plan Involving Financial Strengthening, Strategic Partnerships, Technology Rollouts, and Operational Initiatives to Drive Long-Term Value Creation

BTIG Suspends Neutral Rating on Accuray

Accuray (ARAY) Stock Sees Fair Value Cut After Downgrades And Lower Growth Assumptions

Accuray Incorporated Reports Inducement Award Under NASDAQ Listing Rules

Accuray and the University of Wisconsin-Madison Announce Master Research Agreement to Improve Personalized Care for Patients with Cancer

Accuray And The University of Wisconsin School of Medicine and Public Health Announce A New 10-Year Strategic Collaboration To Advance Personalized Cancer Treatments Using Accuray's Stellar Adaptive Radiation Therapy Platform

Accuray Inc (ARAY) Runs Into Middle East Headwinds, But Shift Plan Is Working

Jefferies Downgrades Accuray to Hold, Lowers Price Target to $0.35

Accuray Slides As Insider Purchases Lose Another US$95k

BTIG Downgrades Accuray to Neutral

Accuray Incorporated (ARAY) Q3 2026 Earnings Call Transcript

Accuray Incorporated 2026 Q3 - Results - Earnings Call Presentation

Accuray (ARAY) Q3 2026 Earnings Transcript